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Background: The objective of this study was to investigate the influence of β2-microglobulin (β2-M) on the
epithelial-mesenchymal transition (EMT) in renal tubular epithelial cells.
Methods: A human kidney proximal tubular cell line (HK-2) was used as the proximal tubular cell model. HK-2 cells
were exposed to different concentrations of β2-M (5, 10, 25, and 50 μM) for up to 24, 48 and 72 h. The effects of
β2-M on cell morphology were observed by phase contrast microscopy, and the possible associated mechanisms
were assessed by immunofluorescence staining, western blot, RNA interference, immunoprecipitation, and induced
coupled plasma mass spectroscopy.
Results: β2-M induced marked morphological alterations in the HK-2 cells, accompanied by the increased expression
of extracellular matrix components and α-smooth muscle actin (α-SMA), vimentin and fibronectin and the reduced
expression of E-cadherin. Our results also revealed that β2-M could induce the EMT in the HK-2 cells without significant
affecting cell viability. Excess β2-M in the HK-2 cells led to a decrease in iron and an increase in hypoxia inducible
factor-1α (HIF-1α), which induced EMT in the HK-2 cells. Additionally, disrupting the function of the β2-M/hemochromatosis
(HFE) complex by HFE knockdown was sufficient to reverse β2-M-mediated EMT in the HK-2 cells.
Conclusion: These findings demonstrate that the activity of β2-M is mediated by the β2-M/HFE complex, which regulates
intracellular iron homeostasis and HIF-1α and ultimately induces EMT in HK2 cells.
Keywords: β2-microglobulin, Epithelial-mesenchymal transition, HemochromatosisBackground
Epithelial-mesenchymal transition (EMT) is a process by
which fully differentiated epithelial cells undergo transition
to a fibroblast phenotype. Emerging evidence has suggested
that EMT is an important pathway leading to the generation
of matrix-producing fibroblasts and myofibroblasts during
the development of kidney fibrosis [1-5].
Protein overload models as well as animal models of
proteinuria induced by renal injury have suggested that
excessive protein reabsorption induces EMT in tubular
cells [6,7]. Qiong Wen et al. [8] have proven that urinary
proteins from patients with nephrotic syndrome alter
signaling proteins regulating EMT. In vitro experiments* Correspondence: weihuagan@njmu.edu.cn
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unless otherwise stated.have found that a high concentration of albumin up-
regulates profibrogenic gene (transforming growth factor-
β1, TGF-β1) expression in proximal tubular cells [9].
β2-microglobulin (β2-M) is an 11-kDa nonglycosylated
protein with no transmembrane domain that usually
associates with cells by interacting with the extracellular
regions of heavy chains. It is typically filtered through the
renal glomeruli, and 99% of it is absorbed and catalyzed
by the renal tubular cells, while the non-absorbed portion
is excreted in the urine. β2-M is also a major protein
component of proteinuria. The appearance of β2-M in the
urine depends on its plasma level, which must exceed its
renal reabsorptive threshold of 5 mg/l, and/or proximal
tubular damage [10]. Many studies have demonstrated
that the serum or urine β2-M concentration is increased
in a variety of diseases, including inflammatory or infec-
tious diseases [11,12], prostate cancer, lung cancer, andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Hodgkin’s lymphoma and multiple myeloma [13-17].
However, the effect of excessive β2-M on proximal tubular
cells is relatively unknown.
Therefore, the main aim of this study was to test the
hypothesis that urinary β2-M can induce EMT human
renal proximal tubule epithelial cells and to elucidate the
molecular mechanism associated with this process.
Methods
Cell cultures and treatments
HK-2 human renal proximal tubular epithelial cells
(PTECs) were purchased from the American Type Culture
Collection (Rockville, MD) and were maintained as
described previously [8]. A β2-M stock solution (1 mM)
was prepared by dissolving 118 mg of lyophilized powder
into 10 ml of serum-free base media. Human serum
albumin (HSA), which is the most abundant protein
in nephrotic urine, was used as a protein control. We
used TGF-β1, which is a classic profibrogenic factor,
as a positive control. The HK-2 cells were exposed to
different concentrations of β2-M, HAS, or TGF-β1 for
various periods of time as scheduled. For neutralizing
antibody assessments, cells were pre-treated for 1 h
prior to the addition of β2-M and subsequently co-treated
with a monoclonal anti-TGF-β1 antibody (TGF-β1 mAb;
R&D Systems, Minneapolis, MN) at a concentration of
30 μg/ml.
Cell viability and preparation of cell lysates
After exposure to the β2-M (5, 10, 25, and 50 μM) or
control medium for 24–72 h, cell viability was measured
by a Cell Titer 96 Aqueous One solution Cell Proliferation
Assay (Promega, Madison, MI). To evaluate the transition
of PTECs to fibroblasts, we used HK-2 cells cultured in
supplement-free fresh media in the presence or absence of
various treatments. After the media were removed,
cellular proteins were extracted by lysing the cells with
Mammalian Cell Lysis Reagents (Sigma). The protein
concentrations in the cellular lysates were determined
by the Bradford method using DC protein assay reagents
(Bio-Rad, Hercules, CA).
Western blot analysis
Western blot analysis was performed essentially according
to an established procedure [18]. The primary antibodies
used were as follows: anti-β-actin (Sigma, St. Louis,
MO), anti-α-SMA (Sigma, St. Louis, MO), anti-E-cadherin
(BD Transduction Laboratories, Lexington, KY), anti-
fibronectin (Santa Cruz Biotechnology, Santa Cruz, CA),
anti-HFE (Santa Cruz Biotechnology, Santa Cruz, CA),
anti-vimentin (Boster, Wuhan, China), and anti-HIF-1α
(Millipore, USA). Quantifications were performed by
measuring band intensities using Image J analysis software.Transient transfection of cells with siRNA
For the knockdown experiments, HK2 cells were tran-
siently transfected with siRNA specifically targeting
HFE or a negative control siRNA using Lipofectamine
PLUS (Invitrogen, Carlsbad, CA) according to the manu-
facturer’s instructions. Cells were transfected with 20 nM
HFE siRNA or control siRNA for 24 h before treatment.
Cellular protein was extracted and subjected to western
blot analysis for HFE.
Immunoprecipitation
Immunoprecipitation was performed using an Immuno-
precipitation Starter Pack (GE Healthcare).
Iron measurements and Iron chelator treatments on
HK-2 cells
Iron concentrations were determined using induced
coupled plasma mass spectroscopy (ICP-MS). A total of
107 cells were pelleted and digested using 3% nitric acid.
Samples were diluted and analyzed with a Perkin Elmer
ICP-MS. The data are expressed as picomoles of metal.
HK-2 cells were treated with 200 mmol/L of desferal (DES)
for 48 h. Then, the DES was removed and replaced with
normal media. A day later, the cells were photographed,
and cell lysates were prepared for immunoblot analysis.
Statistical analysis
All data are expressed as the mean ± S.D. Multiple groups
of values were compared using one-way analysis of
variance (ANOVA) and Fisher’s LSD test. Data were
analyzed using SPSS 13.0 for Windows. A P < 0.05 was
considered significant.
Results
Effect of β2-M on PTEC cellular viability
Considering the absorbance at 490 nm in the control
group as 1, the exposure of HK-2 cells to different
concentrations of β2-M (5, 10, and 25 μM) produced
no significant effects on cell viability at 24, 48 or
72 h; however, a significant decrease in cell viability
(>20%) was observed at the higher doses of ≥50 μM
β2-M after 48 h (Figure 1).
Effect of β2-M on PTEC morphology
The control cells showed a typical epithelial cuboidal
shape with a cobblestone morphology (Figure 2A); however,
they exhibited profound morphologic changes after
exposure to β2-M (25 μM) for 72 h, becoming elongated
in shape, disassociating from neighboring cells and losing
their cobblestone monolayer morphology (Figure 2B).
Because TGF-β1 is a well-characterized inducer of EMT
in renal tubular epithelial cells, it was used as a positive
control (Figure 2C). HSA, which was used as a protein
control, had no significant effect on the morphological
Figure 1 Effects of β2-M treatment on the viability of HK-2 cells.
HK-2 cells were grown to 80% confluence, and then, different
concentrations of β2-M (5, 10, 25, and 50 μM) were added to the
media for an additional 24, 48, and 72 h. The mean and SE of the
absorbance at 490 nm for six replicates normalized to a control was
calculated for each group, considering the absorbance at 490 nm of
the control as 1. **P < 0.05 compared with the control.
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interestingly, a neutralizing TGF-β1 antibody could not
block the β2-M-induced morphological changes of
the HK2 cells (Figure 2E), indicating that β2-M EMT
occurred in a TGF-β1-independent manner.
β2-M induced EMT in HK-2 cells
We further assessed the expression of E-cadherin, which
is a marker for the epithelial phenotype, and α-SMA,Figure 2 Effect of β2-M treatment on the morphology of HK-2 cells. HK-2
medium (A), β2-M (B), TGF-β1 (C), HSA (D), or β2-M + TGF-β1 mAb (E) was
digital camera coupled to a Nikon TMS microscope. For each group, 80 celvimentin, and fibronectin, which are markers for the
myofibroblast phenotype. We observed that in HK-2
cells exposed to 25 μM of β2-M, the expression of
E-cadherin decreased after 72 h of treatment, while
that of α-SMA, vimentin, and fibronectin increased,
as indicated by western blot analysis (Figure 3A and B),
These results suggest that these cells lost their epithe-
lial characteristics and acquired mesenchymal cell
properties.
β2-M interacted with hemochromatosis (HFE) protein and
inhibition of HFE reversed EMT
HFE has been previously shown to interact with β2-M.
We therefore assessed the presence of β2-M and HFE
complexes in HK-2 cells. The physical interaction between
β2-M and HFE as a complex was demonstrated by
coimmunoprecipitation (co-IP) followed by western
blot analyses (Figure 4A). To determine the possible
functional roles of the β2-M/HFE complex in β2-M-
induced EMT in HK-2 cells, we transfected these cells
with either siRNA-HFE or irrelevant siRNA-con. After
24 h, HFE expression was assessed by western blot.
Our results indicated that the level of this protein
was markedly lower in the HK-2 cells transfected with
siRNA-HFE compared with the control cells and those
transfected with siRNA-con (Figure 4B). Interestingly, a
decrease in the HFE protein level blocked the increasedcells were grown in 6-well plates to 80% confluence, and then, control
added for 72 h. The cells were photographed using a JVC KY-FSSBE
ls were measured.
Figure 3 Effect of β2-M treatment on EMT in HK-2 cells. (A) HK-2 cells were stimulated with 25 μM β2-M for 72 h, Cell lysates were immunoblotted
with antibodies against E-cadherin, α-SMA, fibronectin, vimentin, and β-actin. (B) Graphical representation of E-cadherin, α-SMA, vimentin,
and fibronectin protein abundances as indicated. The relative E-cadherin, α-SMA, vimentin, and fibronectin levels were calculated after normalization
to β-actin. The data are presented as the mean ± SE of three experiments. **P < 0.05 versus controls.
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expression of E-cadherin induced by β2-M (Figure 4B
and C). Additionally, we observed that the down-
regulation of the HFE protein altered the morphology
of the HK-2 cells to a cobblestone-like appearance
(Figure 4D). Thus, disrupting the function of the
β2-M/HFE complex by HFE knockdown is sufficient to
reverse β2-M-mediated EMT in HK-2 cells.Figure 4 The β2-M-induced inhibition of HFE reversed the EMT process. (A
anti-HFE Ab. Western blot analysis of HFE. An IgG Ab was used as a contro
vimentin, and α-SMA) in control and HFE knockdown HK-2 cells. (C) Graph
protein abundances after normalization with β-actin as indicated. The data
controls. (D) HFE knockdown in HK-2 cells blocked β2-M activity and induc
Nikon TMS microscope at 400x magnification.β2-M attenuated intracellular iron but increased HIF-1α
expression in HK-2 cells
Because the β2-M protein is known to directly regulate
iron levels in cells as demonstrated by the prevention of
iron uptake by the β2-M/HFE complex and the iron
overload observed in β2-M and HFE knockout mice
(20), we assessed whether cellular iron levels were lower
in β2-M-stimulated HK-2 cells compared to control cells) Immunoprecipitation using a monoclonal anti-β2-M Ab and an
l. (B) Western blot analysis of HFE and EMT markers (E-cadherin,
ical representation of relative HFE, E-cadherin, vimentin, and α-SMA
are presented as the mean ± SE of three experiments. **P < 0.05 versus
ed epithelial-like phenotypic changes. Photographs were taken using a
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(ICP-MS). Intracellular iron was significantly lower in
the β2-M-stimulated HK-2 cells compared to the control
cells (Figure 5A). Additionally, iron-responsive HIF-1α,
which is a factor that has been widely proven to participate
in the EMT process, increased after stimulation with β2-M
for 72 h; however, HFE knockdown reversed the increase
in HIF-1α induced by β2-M (Figure 5B and C).
Iron modulated EMT in HK-2 cells
To further determine whether iron is involved in the
regulation of EMT, we used an iron chelator (DES) to
induce EMT-like changes. DES increased the expression
of iron responsive HIF-1α and induced mesenchymal
characteristics (Figure 6A through C). These results
collectively demonstrate that β2-M overload in HK-2
cells leads to decreased iron and increased HIF-1α,
which induces EMT in HK-2 cells.
Discussion
The role of β2-M has long been documented in many
kidney diseases. In this study, we documented for the
first time that (i) β2-M can promote apoptosis and EMT
in tubular epithelial cells in vitro; (ii) induced the stableFigure 5 The β2-M/HFE complex modulated iron levels and induced HIF-1
were measured by inductively coupled plasma mass spectroscopy. (B) Wes
(C) Graphical representation of relative HIF-1α protein abundances after no
mean ± SE of three experiments. **P < 0.05 versus controls.expression of EMT biomarkers, including the decreased
expression of E-cadherin and increased expression of
α-SMA and fibronectin in HK-2 cells; and (iii) formed
a complex with its receptor, HFE, and this complex
regulated intracellular iron and activated HIF-1α in
HK-2 cells (Figure 7). To our knowledge, this is the
first report to demonstrate the manner by which β2-M
functionally promotes EMT in tubular epithelial cells.
β2-M is a nonglycosylated protein with a molecular
mass of 11,800 Da that is synthesized by all nucleated
cells and forms a small invariable light chain subunit of
major histocompatibility complex (MHC) class I antigen
through noncovalent linkages on cell surfaces. The β2-M
protein is present at low levels in serum, urine and other
body fluids under normal physiological conditions and is
almost exclusively catabolized within the kidney. Many
studies have demonstrated that the serum or urine
β2-M concentration is increased in a variety of diseases,
including inflammatory or infectious diseases [10,11] and
cancers [12-16]. When the elevation in plasma β2-M
exceeds its renal reabsorptive threshold of 5 mg/1 or the
proximal tubules are damaged, β2-M appears in the urine.
In chronic kidney disease, as kidney function gradually
declines, β2-M filtration is reduced and the serum level ofα expression. (A) Iron levels in HK-2 cells and HFE knockdown cells
tern blot analysis of HIF-1α in HK-2 cells and HFE knockdown cells.
rmalization with β-actin as indicated. The data are presented as the
Figure 6 Effect of iron on EMT in HK-2 cells. (A) HK-2 cells were stimulated with DES for 48 h, and photographs were taken using a Nikon TMS
microscope at 400x magnification. (B) HK-2 cells were cultured in the presence or absence of DES for 48 h. Cell lysates were immunoblotted with
antibodies against HIF-1α, E-cadherin, vimentin, and α-SMA. (C) Graphical representation of relative HIF-1α, E-cadherin, vimentin, and α-SMA protein
abundances after normalization with β-actin as indicated. The data are presented as the mean ± SE of three experiments. **P < 0.05 versus controls.
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tively normal residual glomeruli to high concentrations of
β2-M. The excess β2-M filtered from the original urine
can cause damage to renal tubular cells [18].
However, the actual concentration of β2-M in the
proximal tubular ultrafiltrate in patients with proteinuricFigure 7 Working model of β2-M-mediated EMT. The β2-M/HFE complex
pathways, such as HIF-1α signaling.renal diseases is unknown. In systemic lupus erythematosus
and chronic kidney disease patients, the maximum serum
β2-M protein concentration has been reported to
reach ~25 mg/dl [19,20]. Because the relatively small
molecular weight of β2-M permits its filtration through
the glomerular membrane, we chose to use the dose ofmaintains low iron levels and activates EMT via iron-responsive
Zhang et al. BMC Nephrology  (2015) 16:60 Page 7 of 85–50 μM in our in vitro study. As shown in Figure 1,
a significant decrease in cell viability (>20%) was observed
at higher β2-M doses of ≥50 μM after 48 h. In addition,
the induction of fibronectin, vimentin, and α-SMA
expression by β2-M in vitro was dose dependent, and
the maximal induction was observed following treatment
with 25 μM of β2-M (data not shown). We therefore
selected 25 μM of β2-M as the treatment in most of
our cell experiments.
Although a conclusive demonstration of EMT in vivo
in patients with kidney diseases remains a challenge, it
has emerged as an important pathway leading to kidney
fibrosis in diseased kidneys in recent years. The process
of EMT is characterized by a loss of epithelial proteins,
such as E-cadherin and cytokeratin, and the acquisition
of new mesenchymal markers, including vimentin, α-SMA,
fibroblast-specific protein-1 (FSP1), interstitial matrix
components type I collagen, and fibronectin [21,22]. These
alterations in protein expression are usually accompanied
by a change in morphology to a fibroblastoid appearance
and an enhanced migratory capacity. It has been proven
that there is a correlation between the severity of tubular
injury and urine protein quality in various renal diseases
[23]. Additionally, Sajni Josson et al. [24] have found that
β2-M, which is an important component of urine protein,
induces epithelial to mesenchymal transition and confers
cancer lethality and bone metastasis in human cancer cells.
However, the molecular biological mechanism of β2-M in
the damage of renal tubular epithelial cells is far from clear.
In our study, β2-M induced tubular cells to undergo sig-
nificant morphologic changes to a fibroblastoid appearance
and promoted the expression of EMT-related proteins in
these cells. These results indicate that this protein may also
be an important factor in the peritubular microenviron-
ment that induces or promotes EMT. Although we did not
find any new molecular mechanism by which β2-M
induces EMT, our results support the function of the
β2-M/HFE complex as a mediator participating in β2-
M-induced EMT in both renal proximal tubule epithelial
cells and cancer cells. Further, this mechanism may play
an important role in tumor-associated nephropathy
because the concentrations of serum and urine β2-M
have been shown to be increased in many types of
cancer [13-17].
HFE is an MHC class 1b protein that is likely to
assume a signaling role in association with β2-M [25].
β2-M/HFE has been found to regulate negatively
intracellular iron, activate HIF-1α and promote EMT
in cancer cells. Our study demonstrated that HFE is a
β2-M receptor as shown by the following results: (1)
HFE was found to physically interact with β2-M, as
demonstrated by the immunoprecipitation results for
the HK-2 cells (Figure 4A); and (2) the knockdown of
HFE resulted in a reversal of EMT in the HK-2 cellswith supportive morphologic, biochemical, and behavioral
characteristics (Figure 4B-D). Thus, β2-M/HFE interac-
tions are important for β2-M-mediated EMT. In addition,
β2-M protected the influx and accumulation of intra-
cellular iron. Higher β2-M/HFE levels led to the
downregulation of intracellular iron in the HK-2 cells,
and low levels of this complex in these cells enhanced
intracellular iron levels (Figure 5A). Lower levels of
intracellular iron activated HIF-1α and its target genes in
the HK-2 cells (Figures 5B-C and 6), driving EMT. The
downstream functional significance of the β2-M/HFE
complex is depicted in Figure 7.
Conclusion
In summary, we demonstrated the importance of β2-M
in EMT in tubular epithelial cells. The activity of β2-M
is mediated by the β2-M/HFE complex, which regulates
intracellular iron homeostasis and HIF-1α and ultimately
induces EMT. The inhibition of this complex could affect
the process of EMT.
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